NO20055333L - Indazolderivater - Google Patents

Indazolderivater

Info

Publication number
NO20055333L
NO20055333L NO20055333A NO20055333A NO20055333L NO 20055333 L NO20055333 L NO 20055333L NO 20055333 A NO20055333 A NO 20055333A NO 20055333 A NO20055333 A NO 20055333A NO 20055333 L NO20055333 L NO 20055333L
Authority
NO
Norway
Prior art keywords
substituted
unsubstituted
heterocyclic group
hydrogen atom
ararkyl
Prior art date
Application number
NO20055333A
Other languages
English (en)
Inventor
Yukimasa Shiotsu
Yoshihisa Ohta
Fumihiko Kanai
Shinji Nara
Yutaka Kanda
Hiroshi Umehara
Tomoki Naoe
Hitoshi Kiyoi
Keiko Kawashima
Hiromi Ando
Motoki Miyama
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Publication of NO20055333L publication Critical patent/NO20055333L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Det beskrives indazolderivater som representeres ved den generelle formel (I) eller farmakologisk akseptable salter derav: lb derR'erCONRlaR1D,der Rla og Rlb hver uavhengig er hydrogen, lavere alkyl, aryl, aralkyl eller en heterosyklisk gruppe, eller Rla og Rlb sammen med nabo-nitrogenatomet kan danne en heterosyklisk gruppe, eller lignende; og R2 er hydrogen, CONR2aR2b der, R2a og R2b er som definert for Rla og Rlb, NR2cR2d der R2c og R2d hver uavhengig er hydrogen, lavere alkyl, lavere alkanoyl, aroyl, heteroaryl, aralkyl, alkylsulfonyl eller arylsulfonyl, eller lignende.
NO20055333A 2003-07-30 2005-11-11 Indazolderivater NO20055333L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003203508 2003-07-30
PCT/JP2004/011287 WO2005012257A1 (ja) 2003-07-30 2004-07-30 インダゾール誘導体

Publications (1)

Publication Number Publication Date
NO20055333L true NO20055333L (no) 2005-11-11

Family

ID=34113614

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055333A NO20055333L (no) 2003-07-30 2005-11-11 Indazolderivater

Country Status (15)

Country Link
US (2) US7470717B2 (no)
EP (1) EP1652842B1 (no)
JP (1) JP4335212B2 (no)
KR (1) KR20060119705A (no)
CN (1) CN100390149C (no)
AT (1) ATE553092T1 (no)
AU (1) AU2004260756B2 (no)
BR (1) BRPI0408876A (no)
CA (1) CA2518950A1 (no)
EA (1) EA010165B1 (no)
ES (1) ES2384568T3 (no)
MX (1) MXPA05011420A (no)
NO (1) NO20055333L (no)
WO (1) WO2005012257A1 (no)
ZA (1) ZA200509952B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003076438A1 (en) 2002-03-13 2003-09-18 Janssen Pharmaceutica N.V. Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
DK1485354T3 (da) 2002-03-13 2008-09-01 Janssen Pharmaceutica Nv Sulfonylamino-derivater som nye inhibitorer af histandeacetylase
DK1485353T3 (da) 2002-03-13 2011-11-28 Janssen Pharmaceutica Nv Nye inhibitorer af histondeacetylase
KR20040090981A (ko) 2002-03-13 2004-10-27 얀센 파마슈티카 엔.브이. 신규한 히스톤 디아세틸라제 저해제로서의카보닐아미노-유도체
US7470717B2 (en) * 2003-07-30 2008-12-30 Kyowa Hakko Kogyo Co., Ltd. Indazole derivatives
EP1781639B1 (en) 2004-07-28 2012-01-25 Janssen Pharmaceutica NV Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
CA2596527C (en) 2005-01-27 2013-02-12 Kyowa Hakko Kogyo Co., Ltd. Igf-1r inhibitors
EP1878737A4 (en) * 2005-04-28 2010-08-04 Kyowa Hakko Kirin Co Ltd METHOD OF SYNTHESIZING INDAZOLE-3-YLMETHYLPHOSPHONIUM SALT
CA2605272C (en) 2005-05-18 2013-12-10 Janssen Pharmaceutica N.V. Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase
EP1943232B1 (en) * 2005-10-27 2011-05-18 Janssen Pharmaceutica NV Squaric acid derivatives as inhibitors of histone deacetylase
WO2007082878A1 (en) 2006-01-19 2007-07-26 Janssen Pharmaceutica N.V. Aminophenyl derivatives as novel inhibitors of histone deacetylase
US8101616B2 (en) 2006-01-19 2012-01-24 Janssen Pharmaceutica N.V. Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
EP1981875B1 (en) 2006-01-19 2014-04-16 Janssen Pharmaceutica N.V. Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase
AU2007206942B2 (en) 2006-01-19 2012-08-23 Janssen Pharmaceutica N.V. Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
JPWO2008001885A1 (ja) 2006-06-30 2009-11-26 協和発酵キリン株式会社 Ａｂｌキナーゼ阻害剤
US20090209537A1 (en) * 2006-06-30 2009-08-20 Kyowa Hakko Kirin Co., Ltd. Aurora inhibitors
WO2008020606A1 (fr) * 2006-08-16 2008-02-21 Kyowa Hakko Kirin Co., Ltd. Agent anti-angiogénique
GB0619325D0 (en) 2006-09-30 2006-11-08 Univ Strathclyde New compounds
TW200901960A (en) 2007-03-05 2009-01-16 Kyowa Hakko Kogyo Kk Pharmaceutical composition
CA2680122A1 (en) 2007-03-05 2008-09-18 Kyowa Hakko Kirin Co., Ltd. Pharmaceutical composition
WO2008114812A1 (ja) * 2007-03-19 2008-09-25 Kyowa Hakko Kirin Co., Ltd. Jak阻害剤
US20090325964A1 (en) * 2008-05-23 2009-12-31 Wyeth Piperazine Metabotropic Glutamate Receptor 5 (MGLUR5) Negative Allosteric Modulators For Anxiety/Depression
CN103804382A (zh) * 2012-11-05 2014-05-21 韩文毅 一类治疗湿疹的化合物及其用途
CN103804306A (zh) * 2012-11-12 2014-05-21 韩文毅 一类治疗糖尿病的化合物及其用途
GB201511382D0 (en) 2015-06-29 2015-08-12 Imp Innovations Ltd Novel compounds and their use in therapy
MA42953A (fr) 2015-09-22 2018-08-01 Graybug Vision Inc Composés et compositions pour le traitement de troubles oculaires
JP7217022B2 (ja) 2017-03-23 2023-02-02 グレイバグ ビジョン インコーポレイテッド 眼障害の治療のための薬物及び組成物
MX2019013363A (es) 2017-05-10 2020-01-13 Graybug Vision Inc Microparticulas de liberacion extendida y suspensiones de las mismas para terapia medica.
WO2019051396A1 (en) * 2017-09-08 2019-03-14 President And Fellows Of Harvard College SMALL MOLECULE INHIBITORS OF EBOLA VIRUSES AND LASSA FEVER, AND METHODS OF USE THEREOF
MX2021000657A (es) * 2018-07-23 2021-05-12 Celgene Quanticel Res Inc Proceso para la preparacion de inhibidor de bromodominio.

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0232059A (ja) * 1988-07-18 1990-02-01 Kyowa Hakko Kogyo Co Ltd インダゾール誘導体
TWI262914B (en) * 1999-07-02 2006-10-01 Agouron Pharma Compounds and pharmaceutical compositions for inhibiting protein kinases
PE20010306A1 (es) * 1999-07-02 2001-03-29 Agouron Pharma Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
US6632815B2 (en) 1999-09-17 2003-10-14 Millennium Pharmaceuticals, Inc. Inhibitors of factor Xa
YU54202A (sh) 2000-01-18 2006-01-16 Agouron Pharmaceuticals Inc. Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
US7238853B2 (en) 2000-07-14 2007-07-03 Unicrop Ltd Molecular mechanisms for gene containment in plants
US20050009876A1 (en) 2000-07-31 2005-01-13 Bhagwat Shripad S. Indazole compounds, compositions thereof and methods of treatment therewith
US7211594B2 (en) 2000-07-31 2007-05-01 Signal Pharmaceuticals, Llc Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith
US6897231B2 (en) 2000-07-31 2005-05-24 Signal Pharmaceuticals, Inc. Indazole derivatives as JNK inhibitors and compositions and methods related thereto
JP4535680B2 (ja) 2001-04-16 2010-09-01 エーザイ・アール・アンド・ディー・マネジメント株式会社 新規１ｈ−インダゾール化合物
TW200406385A (en) 2002-05-31 2004-05-01 Eisai Co Ltd Pyrazole compound and pharmaceutical composition containing the same
JPWO2004050088A1 (ja) * 2002-12-03 2006-03-30 協和醗酵工業株式会社 Ｊｎｋ阻害剤
US7470717B2 (en) * 2003-07-30 2008-12-30 Kyowa Hakko Kogyo Co., Ltd. Indazole derivatives

Also Published As

Publication number Publication date
CA2518950A1 (en) 2005-02-10
EP1652842A1 (en) 2006-05-03
AU2004260756B2 (en) 2010-03-25
KR20060119705A (ko) 2006-11-24
EA200600333A1 (ru) 2006-06-30
WO2005012257A1 (ja) 2005-02-10
CN1777590A (zh) 2006-05-24
EP1652842A4 (en) 2008-10-01
EP1652842B1 (en) 2012-04-11
US20070117856A1 (en) 2007-05-24
US7919517B2 (en) 2011-04-05
MXPA05011420A (es) 2005-12-12
ZA200509952B (en) 2006-09-27
ATE553092T1 (de) 2012-04-15
ES2384568T3 (es) 2012-07-09
CN100390149C (zh) 2008-05-28
US20090082348A1 (en) 2009-03-26
JP4335212B2 (ja) 2009-09-30
BRPI0408876A (pt) 2006-04-11
US7470717B2 (en) 2008-12-30
AU2004260756A1 (en) 2005-02-10
EA010165B1 (ru) 2008-06-30
JPWO2005012257A1 (ja) 2006-09-14

Similar Documents

Publication Publication Date Title
NO20055333L (no) Indazolderivater
TW200722422A (en) Heterocyclic compound and organic electroluminescent device using the same
GEP20074198B (en) N-aryl-2-oxazolidinone-5-carboxamides and their derivates and their use as antibacterials
MX2007005933A (es) Compuestos de acetamida como fungicidas.
TR199801629A2 (xx) Fungisidal 2 -metoksibenzofenonlar.
DE60208355D1 (de) 2-amino-propanol derivate
NZ541974A (en) Nucleotide phosphoramidates as anticancer agents
HK1068868A1 (en) Retinoid derivatives with antiangiognic, antitutmoral and proapoptotic activities
NO20060219L (no) Forbindelser
FR15C0027I2 (fr) Derives de pyrazolinone
CY1112899T1 (el) Παραγωγα θειαδιαζολινης για τη θεραπεια του καρκινου
NO20072753L (no) 3-Etylidenhydrazinosubstituerte heterocykliske forbindelser som trombopoietinreseptoraktivatorer
DK1643984T3 (da) Anvendelse af parthenolidderivater som antileukæmiske og cytotoksske midler
ATE237612T1 (de) Benzofuranderivate
GB0423405D0 (en) Organic compounds
MXPA05013149A (es) Derivados de imidazol como antagonistas del receptor de glutamato.
DE602004031115D1 (de) Pyrimidinverbindungen mit phosphonatgruppen als antivirale nucleotidanaloga
ATE282605T1 (de) 2-thio-subsituierte imidazolderivative und ihre verwendung in der pharmazie
ATE449773T1 (de) Homomorpholinoxazolidinone als antibakterielle mittel
ATE552003T1 (de) Chinoxalinderivate
DE60330038D1 (de) Neue alpha-ketoamidderivate und deren verwendung
DE60211018D1 (de) Fungizide thiazolderivate
DE60103732D1 (de) Pyrimidinderivate mit antitumor-wirkung
ATE261962T1 (de) Benzonaphtyridin-1,8 derivate
UA89970C2 (ru) Гетероциклические соединения и активаторы рецептора тромбопоэтина